BIO.News Newsletter

Price controls are already hurting drug R&D, especially for rare disease, BIO’s Vice Chair John Crowley told Congress yesterday. Meanwhile, in New York, BIO’s SVP Phyllis Arthur spoke on a panel during the UN General Assembly about what we need to do to get ready for the next pandemic. (653 words, 3 minutes, 15 seconds)

A busy week on Capitol Hill continues with BIO Vice Chair John Crowley testifying on the Inflation Reduction Act’s price controls, and a recap of the bipartisan consensus on PBMs from yesterday. Plus, BIO SVP Phyllis Arthur will speak at UNGA in New York. (679 words, 3 minutes, 23 seconds)

It’s already a busy week on the Hill—starting with legislation introduced yesterday that would fix the Inflation Reduction Act’s orphan drug incentives. Today’s new episode of the I am BIO Podcast explores how biotech is saving the bees. (624 words, 3 minutes, 7 seconds)

Starting a new week with FDA’s plans to modernize animal biotech regulations and how we can improve Hispanic health outcomes. Plus, learn how you can share this newsletter with your colleagues and friends. (598 words, 2 minutes, 59 seconds)

Ending the week with a recap of yesterday’s hearing on the Inflation Reduction Act and a closer look at the winners of BIO’s agriculture and environment awards. (616 words, 3 minutes, 4 seconds)

A new study highlights the scale of PBM concentration and its impact on patients. Planning to apply for SBIR/STTR grants? You don’t want to miss this upcoming opportunity to learn from grant-writing experts and NIH. (604 words, 3 minutes, 1 second)

Busy Wednesday—but first, a look at PASTEUR Act advocacy yesterday from BIO (and Gronk), news on the new COVID vaccines, and BIO’s agriculture and environment awardees. (697 words, 3 minutes, 29 seconds)

The FDA approved updated COVID vaccines as COVID is surging, and we’re marking the one-year anniversary of Biden’s biomanufacturing executive order with a look at what more needs to be done. (566 words, 2 minutes, 49 seconds)

A new week begins with updates on COVID-19 (and possibly to the vaccines) and a boost for biofuels and biotech collaboration at the G20 in India. Plus, Congress is back to work with lots to do on a few BIO priorities. (498 words, 2 minutes, 29 seconds)

Happy Friday. We look at news from China on biotech crops plus what experts have been saying about drug price controls. (553 words, 2 minutes, 45 seconds)